Security Snapshot

Bluejay Diagnostics, Inc. - Common Stock (BJDX) Institutional Ownership

CUSIP: 095633103

13F Institutional Holders and Ownership History from Q4 2021 to Q4 2023

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
1,023,267
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • BJDX - Bluejay Diagnostics, Inc. - Common Stock is tracked under CUSIP 095633103.
  • Latest finished 13F holder period is not available.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 1 to 0 between Q3 2023 and Q4 2023.
  • SEC-reported value moved from $674 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

095633103

Latest holder period

n/a

13F holders

13D/G owners

2

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
BJDX
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 5% 51,061 Armistice Capital, LLC 31 Mar 2026
SABBY MANAGEMENT, LLC 4.9% $7,173 27,587 SABBY MANAGEMENT, LLC 31 Dec 2024

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
9
Latest
n/a
Rows shown
1-9 of 9
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q4 0 $0 -$674 0
2023 Q3 12 $674 -$47,406 $56.17 1
2023 Q2 178,702 $47,406 +$6,504 $0.26 10
2023 Q1 136,756 $55,744 -$59,519 $0.41 10
2022 Q4 301,953 $109,007 +$26,136 $0.38 13
2022 Q3 189,389 $146,000 -$69,701 $0.77 9
2022 Q2 243,200 $258,000 +$161,017 $1.06 10
2022 Q1 87,458 $98,000 -$87,297 $1.12 7
2021 Q4 104,311 $267,000 +$267,000 $2.56 8
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .